» Articles » PMID: 15108364

Repression of the Human Immunodeficiency Virus Type-1 Long Terminal Repeat by the C-Myc Oncoprotein

Overview
Journal J Cell Biochem
Date 2004 Apr 27
PMID 15108364
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The effect of trans-acting factors on cis-acting DNA elements on the HIV-1 promoter are the principal determinant regulating transcriptional activation and repression. Host factors that limit viral replication can contribute to the emergence and maintenance of proviral reservoirs. The current paradigm is that this sub-population of latently infected cells confers a biological advantage to the virus by facilitating evasion of immunologic responses and therapeutic strategies resulting in life-long and persistent infection. In this report, we show that ectopic expression of the nuclear phosphoprotein, c-Myc can inhibit HIV-1 gene expression and virus production in CD4+ T-lymphocytes. The effect exerted does not appear to involve other known functions of c-Myc such as proliferation, or apoptosis. The mechanism does implicate c-Myc in a direct role. We have found evidence that c-Myc can specifically recognize the HIV-1 initiator element surrounding the start site of transcription and linker scanning mutagenesis experiments confirmed a loss of c-Myc-mediated repression in the absence of this region. Moreover, we show that c-Myc can interact with the initiator binding proteins YY-1 and LBP-1 and can cooperate with these factors to synergistically repress HIV-1 LTR transcription. Taken together, these results indicate that c-Myc is an important regulator of HIV-1 transcription that potentially contributes to the latent proviral state.

Citing Articles

Impact of chromatin on HIV-1 latency: a multi-dimensional perspective.

Jones J, Gunderson C, Wigdahl B, Nonnemacher M Epigenetics Chromatin. 2025; 18(1):9.

PMID: 40055755 PMC: 11889793. DOI: 10.1186/s13072-025-00573-x.


Distinctive variation in the U3R region of the 5' Long Terminal Repeat from diverse HIV-1 strains.

Mbondji-Wonje C, Dong M, Wang X, Zhao J, Ragupathy V, Sanchez A PLoS One. 2018; 13(4):e0195661.

PMID: 29664930 PMC: 5903597. DOI: 10.1371/journal.pone.0195661.


Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature.

Gelinas J, Gill D, Hyde S Microbiol Mol Biol Rev. 2018; 82(1).

PMID: 29321222 PMC: 5813883. DOI: 10.1128/MMBR.00051-17.


CNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latency-reversing agents with implications for cure strategies.

Gray L, Cowley D, Welsh C, Lu H, Brew B, Lewin S Mol Psychiatry. 2015; 21(4):574-84.

PMID: 26303660 PMC: 4804184. DOI: 10.1038/mp.2015.111.


Selective targeting of the repressive transcription factors YY1 and cMyc to disrupt quiescent human immunodeficiency viruses.

Barton K, Margolis D AIDS Res Hum Retroviruses. 2012; 29(2):289-98.

PMID: 22866663 PMC: 3552162. DOI: 10.1089/AID.2012.0227.